| Literature DB >> 26566964 |
L M Peters1, B Glanemann2, O A Garden2, B Szladovits1.
Abstract
BACKGROUND: Cholecystocentesis can be part of the diagnostic workup of hepatobiliary disease in small animals, but literature on cytological evaluation of bile is scant.Entities:
Keywords: Bactibilia; Cholecystitis; Cholecystocentesis; Hepatobiliary disease
Mesh:
Year: 2015 PMID: 26566964 PMCID: PMC4913648 DOI: 10.1111/jvim.13645
Source DB: PubMed Journal: J Vet Intern Med ISSN: 0891-6640 Impact factor: 3.333
Figure 1Normal bile. (A) Acellular bile with green‐gray, granular background; dog, 10×. (B) Bilirubin crystals on purple granular background; dog, 100× oil. (C) Columnar biliary epithelial cells; cat, 40× oil. Modified Wright's stain.
Figure 2(A) Mats of variable bacteria admixed with golden bile pigment; dog, 20×. (B) Banana‐shaped zoites identified as Isospora spp.; dog, 100× oil. Modified Wright's stain.
Figure 3(A) Marked neutrophilic inflammation with nuclear streaming; bile, cat, 10×. (B) Degenerate neutrophils with intracellular bacteria; cat, 100× oil. Modified Wright's stain.
CBC and serum biochemistry results comparing Group 1 and Group 2
| Variable (RI) | Group 1 | Group 2 |
| ||
|---|---|---|---|---|---|
| Sample size | Median (min‐max) | Sample size | Median (min‐max) | ||
| Dogs | |||||
| Total bilirubin (0–0.14 mg/dL) | 38 | 1.96 (0.02–54.34) | 13 | 0.81 (0.02–7.79) | .048 |
| ALT (13–88 U/L) | 38 | 800 (34–3233) | 13 | 582 (95–2065) | .40 |
| ALP (19–285 U/L) | 38 | 808 (39–8838) | 13 | 1515 (209–7899) | .18 |
| cPLI (<200 μg/L) | 16 | 130 (30–620) | 9 | 388 (125–650) | .013 |
| Cats | |||||
| Total bilirubin (0–0.18 mg/dL) | 49 | 1.15 (0–20) | 16 | 2.88 (0.07–15.1) | .39 |
| ALT (25–130 U/L) | 49 | 157 (21–2287) | 16 | 259 (34–1642) | .41 |
| GGT (0–2 U/L) | 48 | 2 (0–28) | 16 | 4 (1–13) | .061 |
ALT, Alanine transaminase; ALP, alkaline phosphatase; cPLI, canine pancreatic lipase immunoreactivity; GGT, γ‐glutamyl transferase.
Mann–Whitney U Test, significant difference between groups (P ≤ .05).
Figure 4cPLI concentrations in canine Group 1 (median 130 μg/L; 30–620) and Group 2 (median 388 μg/L; 125–650). Logistic regression analysis, P = .031. Reference interval <200 μg/L (solid line), value suggestive of pancreatitis >400 μg/L (dashed line).
Working diagnoses from dogs and cats with cholecystocentesis
| Dogs Group 1 (n = 38) | Dogs Group 2 (n = 14) |
|---|---|
| Extrahepatic biliary tree (n = 2) | Extrahepatic biliary tree (n = 9) |
| Extrahepatic bile tract obstruction: 1 | Inflammation/infection: 8 |
| Gallbladder mucocele: 1 | w/cholelithiasis: 1 |
| Gallbladder mucocoele & bile peritonitis: 1 | |
| Hepatic (n = 27) | Hepatic (n = 8) |
| Chronic (active) hepatitis: 11 | Cholangiohepatitis: 3 |
| w/accumulation of copper: 7 | w/positive liver culture: 2 |
| Cholangiohepatitis: 5 | Chronic hepatitis: 3 |
| Vacuolar hepatopathy: 6 | Fibrosis: 1 |
| Failure: 3 | Metastatic carcinoma w/insufficiency: 1 |
| Fibrosis: 3 | |
| Necrosis: 2 | |
| Hepatocellular carcinoma: 1 | |
| Metastatic neuroendocrine tumor: 1 | |
| Toxic hepatopathy: 1 | |
| Pancreatic (n = 7) | Pancreatic (n = 4) |
| Pancreatitis: 7 | Pancreatitis: 4 |
| Gastrointestinal (n = 7) | Gastrointestinal (n = 1) |
| Inflammatory bowel disease: 3 | Inflammatory bowel disease: 1 |
| Protein‐losing enteropathy: 3 | |
| w/lymphangiectasia: 1 | |
| Ulcerations: 2 | |
| Colonic plasmacytoma: 1 | |
| Pyloric obstruction: 1 | |
| Others | Others |
| Acute kidney injury: 1 | Hypercholesterolemia: 1 |
| Chronic myeloid leukemia: 1 | Vaginal undifferentiated carcinoma: 1 |
| Granulomatous‐necrotising cerebellitis: 1 | |
| Immune‐mediated thrombocytopenia: 1 | |
| Myxomatous mitral valve disease: 1 |